{"version":"1.0","type":"link","title":"A phase I/II clinical trial of neoadjuvant docetaxel/oxaliplatin/S‑1 (DOS) combination therapy for gastroesophageal junction adenocarcinoma.","author_name":"Kumagai K 외","author_url":"https://prs-insight.online/author/Kumagai%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/121850","thumbnail_width":1200,"thumbnail_height":630}